Safety and Efficacy of Nyxol Eye Drops as a Single Agent and With Adjunctive Low-Dose Pilocarpine Eye Drops in Subjects With Presbyopia
Clinical trial NCT05646719 · COMPLETED
Trial details
- NCT number
- NCT05646719
- Sponsor
- Ocuphire Pharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-22
- Primary completion
- 2023-10-11
- Enrollment
- 333
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.